patient view
This page is a research summary built from public sources (FDA, NIH, clinical trial registries). It is not medical advice.Always talk to your doctor about treatment decisions. Drug information here may be incomplete or out of date — verify with your prescriber and the manufacturer's package insert.
drug · small molecule
regorafenib
Marketedupdated 2mo agoby Bayer AG🔗 ChEMBL
Approvedcommunity read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with 4 approved and 30 investigational indications.
targets
Discoidin domain-containing receptor 2Ephrin type-A receptor 2Fibroblast growth factor receptor 2Mitogen-activated protein kinase 11Platelet-derived growth factor receptor
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that